Fabry disease is an X-linked inherited lysosomal disorder that causes accumulation of
glycosphingolipids in body fluids and tissues, leading to progressive organ damage and …

Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations of the
GLA gene that result in a deficiency of the enzymatic activity of α-galactosidase A and …

As known biomarkers of kidney diseases, N-acetyl-β-d-glucosaminidase (NAG) and β-
galactosidase (β-GAL) are of great importance for the diagnosis and treatment of diseases …

An AIE fluorescent probe (TPh-PyBz-β-gal) was designed and synthesized for β-gal
detection based on a novel AIE fluorophore and receptor unit D-galactose residue …

Fabry disease (FD) is a rare, progressive, X-linked inherited disorder of glycosphingolipid
metabolism. It is a monogenic disease due to α-galactosidase A (α-GAL) enzyme deficiency …

Anderson-Fabry disease (AFD) is a rare multisystem X-linked lysosomal storage disorder
caused by α-galactosidase A enzyme deficiency. Long-term cardiac involvement in AFD …

Abstract β-Galactosidase (β-gal) which is overexpressed in primary ovarian cancer can be
employed as a valuable biomarker for ovarian cancer. Thus, monitoring and imaging …

Abstract Aims Anderson–Fabry disease (AFD) is an X-linked lysosomal storage disorder
associated with multi-organ dysfunction. While native myocardial T1 mapping by magnetic …

Anderson–Fabry disease (AFD) is a lysosomal storage disorder, depending on defects in
alpha galactosidase A activity, due to a mutation in the galactosidase alpha gene …

Abstract In Anderson–Fabry disease (AFD) the impact of left ventricular (LV) function on
cardiac outcome is unknown. Noninvasive LV pressure–strain loop analysis is a new …